Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""AZATHIOPRINE"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1056
Tytuł:
A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo.
Autorzy:
Jafarzadeh, Alireza (AUTHOR)
Pour Mohammad, Arash (AUTHOR)
Khosravi, Mina (AUTHOR)
Amiri, Shila (AUTHOR)
Rasouli, Asma (AUTHOR)
Keramati, Haniyeh (AUTHOR)
Goodarzi, Azadeh (AUTHOR)
Pokaż więcej
Źródło:
Skin Research & Technology. Mar2024, Vol. 30 Issue 3, p1-25. 25p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: thiopurines in the multidrug era-time to rescue our memories over half a century of experience.
Autorzy:
Gros B; Western General Hospital, Edinburgh, UK.
Rodríguez-Lago I; Hospital Universitario de Galdakao, Biocruces Bizkaia Health Research Institute, Bilbao, Spain.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Sep; Vol. 56 (6), pp. 1080-1081.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Azathioprine*/therapeutic use
Mercaptopurine*
Humans
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: is blindly stopping thiopurines without confirming adequate anti-TNF concentrations shortsighted?
Autorzy:
Sousa Freitas Queiroz N; Santa Cruz Hospital, Curitiba, Brazil.
Papamichael K; Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Cheifetz AS; Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Apr; Vol. 55 (7), pp. 887-888.
Typ publikacji:
Letter; Comment
MeSH Terms:
Azathioprine*
Tumor Necrosis Factor Inhibitors*
Humans ; Mercaptopurine
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: thiopurines but not anti-TNF monotherapy are linked to worse pregnancy outcomes in a large population-based study.
Autorzy:
Kinnucan J; Division of Gastroenterology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
Kane S; Division of Gastroenterology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 343-344.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Azathioprine*
Pregnancy Outcome*/epidemiology
Female ; Humans ; Mercaptopurine ; Pregnancy
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Is weekly azathioprine pulse effective and safe in dermatological conditions?
Autorzy:
Verma KK; Department of Dermatology and Venereology, All India Institute of Medical Science, New Delhi, India.
Patra S; Department of Dermatology and Venereology, All India Institute of Medical Science, New Delhi, India.
Bhari N; Department of Dermatology and Venereology, All India Institute of Medical Science, New Delhi, India.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2021 Jan; Vol. 34 (1), pp. e14513. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Azathioprine*/adverse effects
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Humans ; Immunosuppressive Agents/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone.
Autorzy:
Zhou XL; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Zhan TY; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Zhou YH; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Shrestha K; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Lan TJ; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Li W; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14079. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Azathioprine*
Pemphigus*/diagnosis
Pemphigus*/drug therapy
Pemphigus*/genetics
Asian People/genetics ; China ; Humans ; Male ; Prednisone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation.
Autorzy:
Pape S; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.; European Reference Network RARE-LIVER, Hamburg, Germany.
Gevers TJG; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.; European Reference Network RARE-LIVER, Hamburg, Germany.
Vrolijk JM; Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands.
van Hoek B; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
Bouma G; Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
van Nieuwkerk CMJ; Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
Taubert R; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Jaeckel E; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Manns MP; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Papp M; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Sipeki N; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Stickel F; Department of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland.
Efe C; Department of Gastroenterology, Harran University Hospital, Urfa, Turkey.
Ozaslan E; Department of Gastroenterology, Numune Research and Education Hospital, Ankara, Turkey.
Purnak T; Department of Gastroenterology, Hacettepe University, Ankara, Turkey.
Nevens F; Department of Gastroenterology and Hepatology, University Hospital KU Leuven, Leuven, Belgium.; European Reference Network RARE-LIVER, Hamburg, Germany.
Kessener DJN; Department of Gastroenterology and Hepatology, University Clinic of Essen Duisburg, Essen, Germany.
Kahraman A; Department of Gastroenterology and Hepatology, University Clinic of Essen Duisburg, Essen, Germany.
Wedemeyer H; Department of Gastroenterology and Hepatology, University Clinic of Essen Duisburg, Essen, Germany.
Hartl J; 1st Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Schramm C; 1st Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Martin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Lohse AW; 1st Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Heneghan MA; Institute of Liver Studies, King's College Hospital, London, UK.; European Reference Network RARE-LIVER, Hamburg, Germany.
Drenth JPH; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.; European Reference Network RARE-LIVER, Hamburg, Germany.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Sep; Vol. 40 (9), pp. 2164-2171. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Azathioprine*
Hepatitis, Autoimmune*/drug therapy
Europe ; Humans ; Immunosuppressive Agents/adverse effects ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjustment of azathioprine dose should be based on a lower 6-TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers.
Autorzy:
Kang B; Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim TJ; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi J; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Baek SY; Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Ahn S; Department of Mathematics, Ajou University, Suwon, Korea.
Choi R; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Laboratory Medicine, Green Cross Laboratories, Yongin, Korea.
Lee SY; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choe YH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Aug; Vol. 52 (3), pp. 459-470. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Azathioprine/*administration & dosage
Guanine Nucleotides/*blood
Immunosuppressive Agents/*administration & dosage
Inflammatory Bowel Diseases/*drug therapy
Leukopenia/*chemically induced
Pyrophosphatases/*genetics
Thionucleotides/*blood
Adolescent ; Azathioprine/adverse effects ; Child ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Inflammatory Bowel Diseases/blood ; Inflammatory Bowel Diseases/genetics ; Leukopenia/blood ; Leukopenia/genetics ; Leukopenia/prevention & control ; Male ; Methyltransferases/genetics ; Polymorphism, Genetic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: balancing safety and efficacy-6-TGN thresholds in NUDT15 intermediate metabolisers treated with thiopurines.
Autorzy:
Digby-Bell J; Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic, Australia.
Ward MG; Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic, Australia.; Monash University, Melbourne, Vic, Australia.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Aug; Vol. 52 (3), pp. 554-555.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Azathioprine*
Leukopenia*
Humans ; Mercaptopurine
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD.
Autorzy:
van Gennep S; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Konté K; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Meijer B; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Heymans MW; Department of Clinical Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Löwenberg M; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
de Boer NKH; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Sep; Vol. 50 (5), pp. 484-506. Date of Electronic Publication: 2019 Jul 25.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Azathioprine/*adverse effects
Immunosuppressive Agents/*adverse effects
Inflammatory Bowel Diseases/*drug therapy
Leukopenia/*chemically induced
Leukopenia/*etiology
Mercaptopurine/*adverse effects
Azathioprine/pharmacokinetics ; Azathioprine/therapeutic use ; Genetic Predisposition to Disease ; Genotype ; Humans ; Immunosuppressive Agents/pharmacokinetics ; Immunosuppressive Agents/therapeutic use ; Inactivation, Metabolic/genetics ; Inflammatory Bowel Diseases/epidemiology ; Inflammatory Bowel Diseases/genetics ; Inflammatory Bowel Diseases/metabolism ; Leukopenia/epidemiology ; Leukopenia/genetics ; Mercaptopurine/analogs & derivatives ; Mercaptopurine/metabolism ; Mercaptopurine/pharmacokinetics ; Mercaptopurine/therapeutic use ; Risk Factors ; Thioguanine/adverse effects ; Thioguanine/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The use of azathioprine in atopic dermatitis: A review.
Autorzy:
Bracho-Borro M; Service of Dermatology, Hospital General de México 'Dr. Eduardo Liceaga', S. S. (Ministry of Health), Mexico City, Mexico.
Franco-Ruiz PA; Service of Dermatology, Hospital General de México 'Dr. Eduardo Liceaga', S. S. (Ministry of Health), Mexico City, Mexico.
Magaña M; Service of Dermatology, Hospital General de México 'Dr. Eduardo Liceaga', S. S. (Ministry of Health), Mexico City, Mexico.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Sep; Vol. 35 (9), pp. e15665. Date of Electronic Publication: 2022 Jul 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Dermatitis, Atopic*/therapy
Drug-Related Side Effects and Adverse Reactions*
Azathioprine/adverse effects ; Humans ; Immunosuppressive Agents/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease.
Autorzy:
de Beaumais, Tiphaine Adam (AUTHOR)
Lorrain, Simon (AUTHOR)
Mamhoudi, Naura (AUTHOR)
Simonin, Mathieu (AUTHOR)
Martinez Vinson, Christine (AUTHOR)
Medard, Yves (AUTHOR)
Petit, Arnaud (AUTHOR)
Jacqz‐Aigrain, Evelyne (AUTHOR)
Pokaż więcej
Źródło:
British Journal of Clinical Pharmacology. Jan2024, Vol. 90 Issue 1, p209-219. 11p.
Czasopismo naukowe
Szczegóły
Tytuł:
Increased risk of thiopurine-related adverse events in elderly patients with IBD.
Autorzy:
Calafat M; Mallorca, Spain.; Barcelona, Spain.
Mañosa M; Badalona, Spain.; Madrid, Spain.
Cañete F; Badalona, Spain.; Madrid, Spain.
Ricart E; Barcelona, Spain.; Madrid, Spain.
Iglesias E; Córdoba, Spain.
Calvo M; Majadahonda, Spain.
Rodríguez-Moranta F; L'Hospitalet de Llobregat, Spain.
Taxonera C; Madrid, Spain.
Nos P; Madrid, Spain.; Valencia, Spain.
Mesonero F; Madrid, Spain.
Martín-Arranz MD; Madrid, Spain.
Mínguez M; Valencia, Spain.
Gisbert JP; Madrid, Spain.
García-López S; Zaragoza, Spain.
de Francisco R; Oviedo, Spain.
Gomollón F; Madrid, Spain.; Zaragoza, Spain.
Calvet X; Madrid, Spain.; Sabadell, Spain.
Garcia-Planella E; Barcelona, Spain.
Rivero M; Santander, Spain.
Martínez-Cadilla J; Vigo, Spain.
Argüelles F; Sevilla, Spain.
Arias L; Burgos, Spain.
Cimavilla M; Valladolid, Spain.
Zabana Y; Madrid, Spain.; Terrassa, Spain.
Domènech E; Badalona, Spain.; Madrid, Spain.
Pokaż więcej
Corporate Authors:
ENEIDA registry of GETECCU
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Oct; Vol. 50 (7), pp. 780-788. Date of Electronic Publication: 2019 Aug 19.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Azathioprine/*adverse effects
Immunosuppressive Agents/*adverse effects
Inflammatory Bowel Diseases/*drug therapy
Mercaptopurine/*adverse effects
Adult ; Aged ; Azathioprine/administration & dosage ; Cohort Studies ; Databases, Factual ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Male ; Mercaptopurine/administration & dosage ; Middle Aged ; Registries ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1056

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies